Patents by Inventor Elisabet Viayna Gaza

Elisabet Viayna Gaza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazo[1,2-B][1,2,4]triazine derivatives as antiparasitic agents
    Patent number: 10065965
    Abstract: A compound of Formula (I), or a salt thereof, compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT) and leishmaniasis, particularly visceral leishmaniasis (VL).
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: September 4, 2018
    Assignees: GlaxoSmithKline Intellectual Property Development Limited, The University of Dundee
    Inventors: Stephen Brand, Elisabet Viayna Gaza, Ian Gilbert, Eun Jung Ko, Maria Marco Martin, Timothy James Miles, Lars Henrik Sandberg, Michael George Thomas
  • IMIDAZO[1,2-B][1,2,4]TRIAZINE DERIVATIVES AS ANTIPARASITIC AGENTS
    Publication number: 20180141949
    Abstract: A compound of Formula (I), or a salt thereof, compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT) and leishmaniasis, particularly visceral leishmaniasis (VL).
    Type: Application
    Filed: May 26, 2016
    Publication date: May 24, 2018
    Inventors: Stephen BRAND, Elisabet Viayna GAZA, Ian GILBERT, Eun Jung KO, Maria MARCO MARTIN, Timothy James MILES, Lars Henrik SANDBERG, Michael George THOMAS
  • Beta-amyloid-directed multitarget compounds for the treatment of alzheimer's disease
    Patent number: 9238626
    Abstract: The compounds of formula (I), or its pharmaceutically acceptable salts, or any stereoisomer or mixture thereof, wherein: R1 is a (C1-C2) alkyl radical; R2 and R3 are radicals independently selected from the group consisting of F, CI and methyl R4 is H or OH; A is a birradical selected from the group consisting of —(CH2)n— and —(CH2)-phenyl-(CH2)—; t is an integer from 0 to 1; and n is an integer from 8 to 15, are useful for the treatment of Alzheimer's disease.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: January 19, 2016
    Assignees: UNIVERSITAT DE BARCELONA, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE
    Inventors: Diego Muñoz-Torrero López-Ibarra, Nibaldo Manuel Inestrosa Cantín, Elisabet Viayna Gaza, Irene Sola Lao, Santiago Vázquez Cruz
  • Beta-Amyloid-Directed Multitarget Compounds For The Treatment Of Alzheimer's Disease
    Publication number: 20150099776
    Abstract: The compounds of formula (I), or its pharmaceutically acceptable salts, or any stereoisomer or mixture thereof, wherein: R1 is a (C1-C2) alkyl radical; R2 and R3 are radicals independently selected from the group consisting of F, Cl and methyl R4 is H or OH; A is a birradical selected from the group consisting of —(CH2)n— and —(CH2)-phenyl-(CH2)—; t is an integer from 0 to 1; and n is an integer from 8 to 15, are useful for the treatment of Alzheimer's disease.
    Type: Application
    Filed: May 9, 2013
    Publication date: April 9, 2015
    Applicants: PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE, UNIVERSITAT DE BARCELONA
    Inventors: Diego Muñoz-Torrero López-Ibarra, Nibaldo Manuel Inestrosa Cantín, Elisabet Viayna Gaza, Irene Sola Lao, Santiago Vázquez Cruz